CoChat

Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation

Open access
Fernández-Gallego, Nieves, Sánchez-Madrid, Francisco, Cibrian, Danay · 2021 · Cells
Cited by 133

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Aryl hydrocarbon receptor (AHR) is an important regulator of skin barrier function. It also controls immune-mediated skin responses. The AHR modulates various physiological functions by acting as a sensor that mediates environment–cell interactions, particularly during immune and inflammatory responses. Diverse experimental systems have been used to assess the AHR’s role in skin inflammation, including in vitro assays of keratinocyte stimulation and murine models of psoriasis and atopic dermatitis. Similar approaches have addressed the role of AHR ligands, e.g., TCDD, FICZ, and microbiota-derived metabolites, in skin homeostasis and pathology. Tapinarof is a novel AHR-modulating agent that inhibits skin inflammation and enhances skin barrier function. The topical application of tapinarof is being evaluated in clinical trials to treat psoriasis and atopic dermatitis. In the present review, we summarize the effects of natural and synthetic AHR ligands in keratinocytes and inflammatory cells, and their relevance in normal skin homeostasis and cutaneous inflammatory diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells10113176

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 206

  1. Alwan, 2015, Pathogenesis and treatment of psoriasis: Exploiting pathophysiological pathways for precision medicine, Clin. Exp. Rheumatol., 33, S2
  2. Waldman, 2017, Atopic dermatitis: Pathogenesis, Semin. Cutan. Med. Surg., 36, 100, 10.12788/j.sder.2017.036 · DOI
  3. Leonardi, 2003, Etanercept as monotherapy in patients with psoriasis, N. Engl. J. Med., 349, 2014, 10.1056/NEJMoa030409 · DOI · Paper page
  4. Krueger, 2019, IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis, J. Allergy Clin. Immunol., 144, 750, 10.1016/j.jaci.2019.04.029 · DOI · Paper page
  5. Scharschmidt, 2009, Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens, J. Allergy Clin. Immunol., 124, 496, 10.1016/j.jaci.2009.06.046 · DOI · Paper page
  6. Elias, 2008, Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanisms, J. Allergy Clin. Immunol., 121, 1337, 10.1016/j.jaci.2008.01.022 · DOI · Paper page
  7. Furue, 2018, Microbiome analysis of forehead skin in patients with atopic dermatitis and healthy subjects: Implication of Staphylococcus and Corynebacterium, J. Dermatol., 45, 876, 10.1111/1346-8138.14486 · DOI · Paper page
  8. Quintana, 2018, Regulation of the immune response by the Aryl hydrocarbon receptor, Immunity, 48, 19, 10.1016/j.immuni.2017.12.012 · DOI · Paper page
  9. Esser, 2013, Functions of the aryl hydrocarbon receptor in the skin, Semin. Immunopathol., 35, 677, 10.1007/s00281-013-0394-4 · DOI · Paper page
  10. Sutter, 2009, EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes, Proc. Natl. Acad. Sci. USA, 106, 4266, 10.1073/pnas.0900874106 · DOI · Paper page
  11. Kennedy, 2013, 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation, Toxicol. Sci., 132, 235, 10.1093/toxsci/kfs325 · DOI · Paper page
  12. Kopf, 2010, 2,3,7,8-tetrachlorodibenzo-p-dioxin increases reactive oxygen species production in human endothelial cells via induction of cytochrome P4501A1, Toxicol. Appl. Pharmacol., 245, 91, 10.1016/j.taap.2010.02.007 · DOI · Paper page
  13. Mascanfroni, 2015, Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α, Nat. Med., 21, 638, 10.1038/nm.3868 · DOI · Paper page
  14. Flaveny, 2009, Transgenic humanized AHR mouse reveals differences between human and mouse AHR ligand selectivity, Mol. Cell. Biol., 1, 119
  15. Flaveny, 2008, The mouse and human Ah receptor differ in recognition of LXXLL motifs, Arch. Biochem. Biophys., 471, 215, 10.1016/j.abb.2008.01.014 · DOI
  16. Flaveny, 2010, Differential gene regulation by the human and mouse aryl hydrocarbon receptor, Toxicol. Sci., 114, 217, 10.1093/toxsci/kfp308 · DOI · Paper page
  17. Forgacs, 2013, Comparative analysis of temporal and dose-dependent TCDD-elicited gene expression in human, mouse, and rat primary hepatocytes, Toxicol. Sci., 133, 54, 10.1093/toxsci/kft028 · DOI
  18. Sogawa, 1986, Location of regulatory elements responsible for drug induction in the rat cytochrome P-450c gene, Proc. Natl. Acad. Sci. USA, 83, 8044, 10.1073/pnas.83.21.8044 · DOI · Paper page
  19. Lusska, 1993, Protein-DNA interactions at a dioxin-responsive enhancer. Analysis of six bona fide DNA-binding sites for the liganded Ah receptor, J. Biol. Chem., 268, 6575, 10.1016/S0021-9258(18)53289-0 · DOI · Paper page
  20. Durrin, 1987, In situ protein-DNA interactions at a dioxin-responsive enhancer associated with the cytochrome P1-450 gene, Mol. Cell. Biol., 7, 3008
  21. Denison, 1988, Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer, Proc. Natl. Acad. Sci. USA, 85, 2528, 10.1073/pnas.85.8.2528 · DOI · Paper page
  22. Mimura, 1999, Identification of a novel mechanism of regulation of Ah (dioxin) receptor function, Genes Dev., 13, 20, 10.1101/gad.13.1.20 · DOI · Paper page
  23. MacPherson, 2014, Aryl hydrocarbon receptor repressor and TiPARP (ARTD14) use similar, but also distinct mechanisms to repress aryl hydrocarbon receptor signaling, Int. J. Mol. Sci., 15, 7939, 10.3390/ijms15057939 · DOI
  24. Grimaldi, 2018, The aryl hydrocarbon receptor regulates the expression of TIPARP and its cis long non-coding RNA, TIPARP-AS1, Biochem. Biophys. Res. Commun., 495, 2356, 10.1016/j.bbrc.2017.12.113 · DOI
  25. Burbach, 1992, Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor, Proc. Natl. Acad. Sci. USA, 89, 8185, 10.1073/pnas.89.17.8185 · DOI · Paper page
  26. Ema, 1992, cDNA cloning and structure of mouse putative Ah receptor, Biochem. Biophys. Res. Commun., 184, 246, 10.1016/0006-291X(92)91185-S · DOI · Paper page
  27. Gu, 2000, The PAS superfamily: Sensors of environmental and developmental signals, Annu. Rev. Pharmacol. Toxicol., 40, 519, 10.1146/annurev.pharmtox.40.1.519 · DOI · Paper page
  28. Antonsson, 1995, Distinct roles of the molecular chaperone hsp90 in modulating dioxin receptor function via the basic helix-loop-helix and PAS domains, Mol. Cell. Biol., 15, 756, 10.1128/MCB.15.2.756 · DOI · Paper page
  29. Ko, 1996, Dioxin-induced CYP1A1 transcription in vivo: The aromatic hydrocarbon receptor mediates transactivation, enhancer-promoter communication, and changes in chromatin structure, Mol. Cell. Biol., 16, 430, 10.1128/MCB.16.1.430 · DOI · Paper page
  30. Enan, 1995, Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions, Biochem. Pharmacol., 49, 249, 10.1016/S0006-2952(94)00430-7 · DOI
  31. Enan, 1996, Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway, Biochem. Pharmacol., 52, 1599, 10.1016/S0006-2952(96)00566-7 · DOI · Paper page
  32. Carver, 1994, The 90-kDa heat shock protein is essential for Ah receptor signaling in a yeast expression system, J. Biol. Chem., 269, 30109, 10.1016/S0021-9258(18)43782-9 · DOI · Paper page
  33. Petrulis, 2003, The hsp90 co-chaperone XAP2 alters importin β recognition of the bipartite nuclear localization signal of the Ah receptor and represses transcriptional activity, J. Biol. Chem., 278, 2677, 10.1074/jbc.M209331200 · DOI · Paper page
  34. Kazlauskas, 2001, The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor, Mol. Cell. Biol., 21, 2594, 10.1128/MCB.21.7.2594-2607.2001 · DOI · Paper page
  35. Ikuta, 2000, Nucleocytoplasmic shuttling of the aryl hydrocarbon receptor, J. Biochem., 127, 503, 10.1093/oxfordjournals.jbchem.a022633 · DOI · Paper page
  36. Reyes, 1992, Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor, Science, 256, 1193, 10.1126/science.256.5060.1193 · DOI · Paper page
  37. Wu, 1992, Mechanism of dioxin action: Ah receptor-mediated increase in promoter accessibility in vivo, Proc. Natl. Acad. Sci. USA, 89, 4811, 10.1073/pnas.89.11.4811 · DOI · Paper page
  38. Morgan, 1992, Transcription-dependent and transcription-independent nucleosome disruption induced by dioxin, Proc. Natl. Acad. Sci. USA, 89, 11622, 10.1073/pnas.89.23.11622 · DOI
  39. Taylor, 2009, Roles of coactivator proteins in dioxin induction of CYP1A1 and CYP1B1 in human breast cancer cells, Toxicol. Sci., 107, 1, 10.1093/toxsci/kfn217 · DOI
  40. Kurita, 2014, The Ah receptor recruits IKKα to its target binding motifs to phosphorylate serine-10 in histone H3 required for transcriptional activation, Toxicol. Sci., 139, 121, 10.1093/toxsci/kfu027 · DOI
  41. Ohtake, 2003, Modulation of oestrogen receptor signalling by association with the activated dioxin receptor, Nature, 423, 545, 10.1038/nature01606 · DOI · Paper page
  42. Wilson, 2013, The tumor suppressor kruppel-like factor 6 is a novel aryl hydrocarbon receptor DNA binding partner, J. Pharmacol. Exp. Ther., 345, 419, 10.1124/jpet.113.203786 · DOI
  43. Kim, 2000, The RelA NF-κB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells, Oncogene, 19, 5498, 10.1038/sj.onc.1203945 · DOI · Paper page
  44. Miao, 2005, Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: Direct cross-talk between phase I and II drug-metabolizing enzymes, J. Biol. Chem., 280, 20340, 10.1074/jbc.M412081200 · DOI · Paper page
  45. Tian, 2002, Ah receptor and NF-κB interactions: Mechanisms and physiological implications, Chem. Biol. Interact., 141, 97, 10.1016/S0009-2797(02)00068-6 · DOI · Paper page
  46. Miniero, 2001, An overview of TCDD half-life in mammals and its correlation to body weight, Chemosphere, 43, 839, 10.1016/S0045-6535(00)00442-2 · DOI
  47. Rannug, 2018, The tryptophan derivative 6-formylindolo [3,2-b]carbazole, FICZ, a dynamic mediator of endogenous aryl hydrocarbon receptor signaling, balances cell growth and differentiation, Crit. Rev. Toxicol., 48, 555, 10.1080/10408444.2018.1493086 · DOI
  48. Sakurai, 2017, The crystal structure of the AhRR–ARNT heterodimer reveals the structural basis of the repression of AhR-mediated transcription, J. Biol. Chem., 292, 17609, 10.1074/jbc.M117.812974 · DOI · Paper page
  49. Oshima, 2007, Molecular mechanism of transcriptional repression of AhR repressor involving ANKRA2, HDAC4, and HDAC5, Biochem. Biophys. Res. Commun., 364, 276, 10.1016/j.bbrc.2007.09.131 · DOI
  50. Davarinos, 1996, Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export, J. Biol. Chem., 274, 28708, 10.1074/jbc.274.40.28708 · DOI · Paper page
  51. Roberts, 1999, Degradation of the basic helix-loop-helix/Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway, J. Biol. Chem., 274, 36351, 10.1074/jbc.274.51.36351 · DOI · Paper page
  52. Corre, 2006, Aryl hydrocarbon receptor- and calcium-dependent induction of the chemokine CCL1 by the environmental contaminant benzo[a]pyrene, J. Biol. Chem., 281, 19906, 10.1074/jbc.M601192200 · DOI
  53. Ohtake, 2007, Dioxin receptor is a ligand-dependent E3 ubiquitin ligase, Nature, 446, 562, 10.1038/nature05683 · DOI · Paper page
  54. Kawajiri, 2017, The aryl hydrocarbon receptor: A multifunctional chemical sensor for host defense and homeostatic maintenance, Exp. Anim., 66, 75, 10.1538/expanim.16-0092 · DOI · Paper page
  55. Neavin, D.R., Liu, D., Ray, B., and Weinshilboum, R.M. (2018). The role of the aryl hydrocarbon receptor (AHR) in immune and inflammatory diseases. Int. J. Mol. Sci., 19. · DOI · Paper page
  56. Furue, M. (2020). Regulation of skin barrier function via competition between AHR axis versus IL-13/IL-4–JAK–STAT6/STAT3 axis: Pathogenic and therapeutic implications in atopic dermatitis. J. Clin. Med., 9. · DOI
  57. Singh, N.P., Singh, U.P., Singh, B., Price, R.L., Nagarkatti, M., and Nagarkatti, P.S. (2011). Activation of Aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of Foxp3 and IL-17 expression and amelioration of experimental colitis. PLoS ONE, 6. · DOI · Paper page
  58. Gandhi, 2010, Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells, Nat. Immunol., 11, 846, 10.1038/ni.1915 · DOI · Paper page
  59. Veldhoen, 2009, Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells, J. Exp. Med., 206, 43, 10.1084/jem.20081438 · DOI · Paper page
  60. Cibrian, 2016, CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis, Nat. Immunol., 17, 985, 10.1038/ni.3504 · DOI · Paper page
  61. Duarte, J.H., Di Meglio, P., Hirota, K., Ahlfors, H., and Stockinger, B. (2013). Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo. PLoS ONE, 8. · DOI · Paper page
  62. Cibrian, 2021, Dissecting the complexity of γδ T cell subsets in skin homeostasis, inflammation, and malignancy, J. Allergy Clin. Immunol., 147, 2030, 10.1016/j.jaci.2020.11.023 · DOI
  63. Cibrian, 2020, Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation, J. Allergy Clin. Immunol., 145, 199, 10.1016/j.jaci.2019.09.025 · DOI
  64. Walker, 2019, Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice, Mol. Psychiatry, 24, 1523, 10.1038/s41380-018-0076-7 · DOI · Paper page
  65. Kaper, T., Looger, L.L., Takanaga, H., Platten, M., Steinman, L., and Frommer, W.B. (2007). Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle. PLoS Biol., 5. · DOI · Paper page
  66. Kadow, 2011, Aryl hydrocarbon receptor is critical for homeostasis of invariant gammadelta T cells in the murine epidermis, J. Immunol., 187, 3104, 10.4049/jimmunol.1100912 · DOI · Paper page
  67. Zaid, 2014, Persistence of skin-resident memory T cells within an epidermal niche, Proc. Natl. Acad. Sci. USA, 111, 5307, 10.1073/pnas.1322292111 · DOI · Paper page
  68. Shin, 2013, Tissue-resident memory T cells, Immunol. Rev., 255, 165, 10.1111/imr.12087 · DOI · Paper page
  69. Cheuk, 2014, Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis, J. Immunol., 192, 3111, 10.4049/jimmunol.1302313 · DOI · Paper page
  70. Vu, T.T., Koguchi-Yoshioka, H., and Watanabe, R. (2021). Skin-resident memory T cells: Pathogenesis and implication for the treatment of psoriasis. J. Clin. Med., 10. · DOI
  71. Gonzalez, 2016, Aryl hydrocarbon receptor influences nitric oxide and arginine production and alters M1/M2 macrophage polarization, Life Sci., 155, 76, 10.1016/j.lfs.2016.05.001 · DOI
  72. Kim, 2014, Increased expression of the aryl hydrocarbon receptor in patients with chronic inflammatory skin diseases, Exp. Dermatol., 23, 278, 10.1111/exd.12350 · DOI · Paper page
  73. Kim, 2021, Aryl hydrocarbon Receptor and autophagy-related protein microtubule-associated protein light chain 3 expression in psoriasis, Ann. Dermatol., 33, 138, 10.5021/ad.2021.33.2.138 · DOI · Paper page
  74. Loertscher, 2001, 2,3,7,8-tetrachlorodibenzo-p-dioxin alters the differentiation pattern of human keratinocytes in organotypic culture, Toxicol. Appl. Pharmacol., 175, 121, 10.1006/taap.2001.9202 · DOI
  75. Loertscher, 2002, In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin causes accelerated terminal differentiation in fetal mouse skin, Toxicol. Pathol., 7, 465
  76. Hashimoto-Hachiya, A., Tsuji, G., Murai, M., Yan, X., and Furue, M. (2018). Upregulation of FLG, LOR, and IVL expression by rhodiola crenulata root extract via Aryl hydrocarbon receptor: Differential involvement of OVOL1. Int. J. Mol. Sci., 19. · DOI · Paper page
  77. Tsuji, 2017, Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis, Cell Death Dis., 8, e2931, 10.1038/cddis.2017.322 · DOI · Paper page
  78. Park, 1996, Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage, Proc. Natl. Acad. Sci. USA, 93, 2322, 10.1073/pnas.93.6.2322 · DOI · Paper page
  79. Ward, 1997, Lesions of Aryl-hydrocarbon receptor-deficient mice, Vet. Pathol., 34, 605, 10.1177/030098589703400609 · DOI · Paper page
  80. Geng, 2006, Targeted ablation of Arnt in mouse epidermis results in profound defects in desquamation and epidermal barrier function, J. Cell Sci., 119, 4901, 10.1242/jcs.03282 · DOI · Paper page
  81. Zhu, 2020, Aryl hydrocarbon receptor in cutaneous vascular endothelial cells restricts psoriasis development by negatively regulating neutrophil recruitment, J. Invest. Dermatol., 140, 1233, 10.1016/j.jid.2019.11.022 · DOI
  82. Uberoi, 2021, Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor, Cell Host Microbe, 29, 1235, 10.1016/j.chom.2021.05.011 · DOI · Paper page
  83. Wyatt, M., and Greathouse, K.L. (2021). Targeting dietary and microbial tryptophan-indole metabolism as therapeutic approaches to colon cancer. Nutrients, 13. · doi:10.20944/preprints202103.0231.v1
  84. Bilir, 2017, Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?, J. Oncol. Sci., 3, 52, 10.1016/j.jons.2017.04.001 · DOI
  85. Nguyen, 2010, Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism, Proc. Natl. Acad. Sci. USA, 107, 19961, 10.1073/pnas.1014465107 · DOI · Paper page
  86. Vogel, 2008, Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase, Biochem. Biophys. Res. Commun., 375, 331, 10.1016/j.bbrc.2008.07.156 · DOI · Paper page
  87. Munn, 2002, Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase, Science, 297, 1867, 10.1126/science.1073514 · DOI · Paper page
  88. Li, 2016, Tolerogenic phenotype of IFN-γ–induced IDO+ dendritic cells is maintained via an autocrine IDO–kynurenine/AhR–IDO loop, J. Immunol., 197, 962, 10.4049/jimmunol.1502615 · DOI · Paper page
  89. DiNatale, 2010, Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling, Toxicol. Sci., 115, 89, 10.1093/toxsci/kfq024 · DOI · Paper page
  90. Mezrich, 2010, An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells, J. Immunol., 185, 3190, 10.4049/jimmunol.0903670 · DOI · Paper page
  91. Lowe, M.M., Mold, J.E., Kanwar, B., Huang, Y., Louie, A., Pollastri, M.P., Wang, C., Patel, G., Franks, D.G., and Schlezinger, J. (2014). Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production. PLoS ONE, 9. · DOI · Paper page
  92. Mellor, 2003, Cutting edge: Induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion, J. Immunol., 171, 1652, 10.4049/jimmunol.171.4.1652 · DOI · Paper page
  93. Fallarino, 2006, The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells, J. Immunol., 176, 6752, 10.4049/jimmunol.176.11.6752 · DOI · Paper page
  94. Fallarino, 2006, Tryptophan catabolism generates autoimmune-preventive regulatory T cells, Transpl. Immunol., 17, 58, 10.1016/j.trim.2006.09.017 · DOI
  95. Platten, 2005, Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite, Science, 310, 850, 10.1126/science.1117634 · DOI · Paper page
  96. Criado, 2009, Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis, Arthritis Rheum., 60, 1342, 10.1002/art.24446 · DOI · Paper page
  97. Elizei, 2018, IDO-expressing fibroblasts suppress the development of Imiquimod-induced psoriasis-like dermatitis, Cell Transplant., 27, 557, 10.1177/0963689718757482 · doi:10.1177/0963689718757482
  98. Merlo, 2016, IDO2: A pathogenic mediator of inflammatory autoimmunity, Clin. Med. Insights Pathol., 9, 21
  99. Fujii, K., Yamamoto, Y., Mizutani, Y., Saito, K., and Seishima, M. (2020). Indoleamine 2,3-dioxygenase 2 deficiency exacerbates Imiquimod-induced psoriasis-like skin inflammation. Int. J. Mol. Sci., 21. · DOI
  100. Bonay, 2017, Immune cells from patients with psoriasis are defective in inducing indoleamine 2,3-dioxygenase expression in response to inflammatory stimuli, Br. J. Dermatol., 176, 695, 10.1111/bjd.14779 · DOI
  101. Harden, 2016, The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases, J. Allergy Clin. Immunol., 137, 1830, 10.1016/j.jaci.2015.09.055 · DOI
  102. Wang, M., Wang, Y., Zhang, M., Duan, Q., Chen, C., Sun, Q., Liu, M., Zheng, Y., and Shao, Y. (2021). Kynureninase contributes to the pathogenesis of psoriasis through pro-inflammatory effect. J. Cell. Physiol., epub ahead of print. · DOI
  103. Clement, 2021, 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine, Nat. Commun., 12, 4447, 10.1038/s41467-021-24785-3 · doi:10.1038/s41467-021-24785-3
  104. Wang, 2017, Kynurenic acid downregulates IL-17/1L-23 axis in vitro, Mol. Cell. Biochem., 431, 55, 10.1007/s11010-017-2975-3 · DOI
  105. Poormasjedi-Meibod, M.S., Hartwell, R., Kilani, R.T., and Ghahary, A. (2014). Anti-scarring properties of different tryptophan derivatives. PLoS ONE, 9. · DOI · Paper page
  106. Dolivo, 2018, Tryptophan metabolites kynurenine and serotonin regulate fibroblast activation and fibrosis, Cell. Mol. Life Sci., 75, 3663, 10.1007/s00018-018-2880-2 · DOI
  107. Leung, 2016, Kynurenine modulates MMP-1 and Type-I Collagen expression via Aryl hydrocarbon receptor activation in dermal fibroblasts, J. Cell. Physiol., 231, 2749, 10.1002/jcp.25383 · DOI
  108. Pakyari, 2016, Development of a nanofibrous wound dressing with an antifibrogenic properties in vitro and in vivo model, J. Biomed. Mater. Res. Part A, 104, 2334, 10.1002/jbm.a.35770 · DOI
  109. Murai, 2018, An endogenous tryptophan photo-product, FICZ, is potentially involved in photo-aging by reducing TGF-β-regulated collagen homeostasis, J. Dermatol. Sci., 89, 19, 10.1016/j.jdermsci.2017.10.002 · DOI
  110. Murai, 2018, Tryptophan photo-product FICZ upregulates AHR/MEK/ERK-mediated MMP1 expression: Implications in anti-fibrotic phototherapy, J. Dermatol. Sci., 91, 97, 10.1016/j.jdermsci.2018.04.010 · DOI
  111. Nestor, 2021, A randomized, double-blind, active- and placebo-controlled trial evaluating a novel topical treatment for keloid scars, J. Drugs Dermatol., 20, 964, 10.36849/JDD.6197 · doi:10.36849/jdd.6197
  112. Papp, 2018, The safety and tolerability of topically delivered kynurenic acid in humans. A phase 1 randomized double-blind clinical trial, J. Pharm. Sci., 107, 1572, 10.1016/j.xphs.2018.01.023 · DOI
  113. Bittinger, 2003, Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor, Mol. Pharmacol., 64, 550, 10.1124/mol.64.3.550 · DOI
  114. Hsu, 2018, 5-hydroxytryptophan attenuates imiquimod-induced psoriasiform dermatitis probably through inhibition of IL-17A production and keratinocyte activation, Exp. Dermatol., 27, 1273, 10.1111/exd.13781 · DOI
  115. Shen, 2021, Serum 5-hydroxytryptamine is related to psoriasis severity in patients with comorbid anxiety or depression, Acta Derm. Venereol., 101, adv00514, 10.2340/00015555-3857 · doi:10.2340/00015555-3857
  116. Matiushenko, 2020, Neurotransmitter imbalance in serum of psoriatic patients in exacerbation stage with comorbid psychoemotional disorders, Dermatol. Ther., 33, e13337, 10.1111/dth.13337 · doi:10.1111/dth.13337
  117. Younes, 2016, Immunohistochemical evaluation of role of serotonin in pathogenesis of psoriasis, J. Clin. Diagn. Res., 10, EC05
  118. Huang, 2004, Immunohistochemical study of serotonin in lesions of chronic eczema, Int. J. Dermatol., 43, 723, 10.1111/j.1365-4632.2004.02196.x · doi:10.1111/j.1365-4632.2004.02196.x
  119. Wetterberg, 2011, Time-dependent modulation of serotonin and its receptors 1A and 2A expression in allergic contact dermatitis, J. Eur. Acad. Dermatol. Venereol., 25, 1200, 10.1111/j.1468-3083.2010.03952.x · DOI
  120. Rasul, 2016, Serotonergic markers in atopic dermatitis, Acta Derm. Venereol., 96, 732
  121. Thorslund, 2009, The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis, Arch. Dermatol. Res., 301, 449, 10.1007/s00403-009-0933-y · DOI
  122. Thorslund, 2013, The expression of serotonin transporter protein correlates with the severity of psoriasis and chronic stress, Arch. Dermatol. Res., 305, 99, 10.1007/s00403-012-1303-8 · DOI
  123. Rogers, 1998, Activation of the Ah receptor by tryptophan and tryptophan metabolites, Biochemistry, 37, 11508, 10.1021/bi980087p · DOI · Paper page
  124. Bergander, 2012, Tryptamine serves as a proligand of the AhR transcriptional pathway whose activation is dependent of monoamine oxidases, Mol. Endocrinol., 26, 1542, 10.1210/me.2011-1351 · DOI · Paper page
  125. Rouse, 2013, Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells, Br. J. Pharmacol., 169, 1305, 10.1111/bph.12205 · DOI · Paper page
  126. Li, 2011, Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation, Cell, 147, 629, 10.1016/j.cell.2011.09.025 · DOI · Paper page
  127. Kahalehili, 2021, Dietary indole-3-carbinol activates AhR in the gut, alters Th17-microbe interactions, and exacerbates insulitis in NOD mice, Front. Immunol., 11, 606441, 10.3389/fimmu.2020.606441 · DOI
  128. Powell, 2020, Indoles from the commensal microbiota act via the AHR and IL-10 to tune the cellular composition of the colonic epithelium during aging, Proc. Natl. Acad. Sci., 117, 21519, 10.1073/pnas.2003004117 · DOI
  129. Peng, 2021, Indole-3-carbinol ameliorates necroptosis and inflammation of intestinal epithelial cells in mice with ulcerative colitis by activating aryl hydrocarbon receptor, Exp. Cell Res., 404, 112638, 10.1016/j.yexcr.2021.112638 · DOI
  130. Na, 2011, Indole-3-acetic acid: A potential new photosensitizer for photodynamic therapy of acne vulgaris, Lasers Surg. Med., 43, 200, 10.1002/lsm.21029 · DOI
  131. Kwon, 2014, A new therapeutic option for facial seborrhoeic dermatitis: Indole-3-acetic acid photodynamic therapy, J. Eur. Acad. Dermatol. Venereol., 28, 94, 10.1111/jdv.12070 · DOI
  132. Grandi, 2016, Indole 3-acetic acid-photodynamic therapy in the treatment of multiple actinic keratoses: A proof of concept pilot study, Photodiagnosis Photodyn. Ther., 16, 17, 10.1016/j.pdpdt.2016.08.006 · DOI
  133. Helferich, 1991, Ultraviolet photoproducts of tryptophan can act as dioxin agonists, Mol. Pharmacol., 40, 674
  134. Ma, 2011, Discovery and biological characterization of 1-(1H-indol-3-yl)-9H-pyrido[3,4-b]indole as an aryl hydrocarbon receptor activator generated by photoactivation of tryptophan by sunlight, Chem. Biol. Interact., 193, 119, 10.1016/j.cbi.2011.05.010 · DOI
  135. Bergander, 2005, Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity, Toxicol. Sci., 85, 935, 10.1093/toxsci/kfi154 · DOI · Paper page
  136. Wei, 1998, Rapid and transient induction of CYP1A1 gene expression in human cells by the tryptophan photoproduct 6-formylindolo[3,2- b]carbazole, Chem. Biol. Interact., 110, 39, 10.1016/S0009-2797(97)00111-7 · DOI · Paper page
  137. Wincent, 2009, The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans, J. Biol. Chem., 284, 2690, 10.1074/jbc.M808321200 · DOI · Paper page
  138. Smirnova, 2016, Evidence for new light-independent pathways for generation of the endogenous aryl hydrocarbon receptor agonist FICZ, Chem. Res. Toxicol., 29, 75, 10.1021/acs.chemrestox.5b00416 · DOI · Paper page
  139. Cardinali, G., Flori, E., Mastrofrancesco, A., Mosca, S., Ottaviani, M., Dell’Anna, M.L., Truglio, M., Vento, A., Zaccarini, M., and Zouboulis, C.C. (2021). Anti-inflammatory and pro-differentiating properties of the Aryl hydrocarbon receptor ligands NPD-0614-13 and NPD-0614-24: Potential therapeutic benefits in psoriasis. Int. J. Mol. Sci., 22. · DOI
  140. Arfaoui, L. (2021). Dietary plant polyphenols: Effects of food processing on their content and bioavailability. Molecules, 26. · DOI · Paper page
  141. Omar, F., Tareq, A.M., Alqahtani, A.M., Dhama, K., Sayeed, M.A., Emran, T.B., and Simal-Gandara, J. (2021). Plant-based indole alkaloids: A comprehensive overview from a pharmacological perspective. Molecules, 26. · DOI · Paper page
  142. Bjeldanes, 1991, Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: Comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin, Proc. Natl. Acad. Sci. USA, 88, 9543, 10.1073/pnas.88.21.9543 · DOI · Paper page
  143. Chen, 1996, Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells, Biochem. Pharmacol., 51, 1069, 10.1016/0006-2952(96)00060-3 · DOI · Paper page
  144. Chen, 1995, Regulation of CYP1A1 by indolo[3,2-b]carbazole in murine hepatoma cells, J. Biol. Chem., 270, 22548, 10.1074/jbc.270.38.22548 · DOI · Paper page
  145. Zákostelská, Z., Málková, J., Klimešová, K., Rossmann, P., Hornová, M., Novosádová, I., Stehlíková, Z., Kostovčík, M., Hudcovic, T., and Štepánková, R. (2016). Intestinal microbiota promotes psoriasis-like skin inflammation by enhancing Th17 response. PLoS ONE, 11. · DOI · Paper page
  146. Stehlikova, 2019, Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model, Front. Microbiol., 10, 236, 10.3389/fmicb.2019.00236 · DOI
  147. Singh, 2016, Dietary indoles suppress delayed-type hypersensitivity by inducing a switch from proinflammatory Th17 cells to anti-inflammatory regulatory T cells through regulation of microRNA, J. Immunol., 196, 1108, 10.4049/jimmunol.1501727 · DOI · Paper page
  148. Wu, 2021, 3,3′-Diindolylmethane alleviates acute atopic dermatitis by regulating T cell differentiation in a mouse model, Mol. Immunol., 130, 104, 10.1016/j.molimm.2020.11.013 · DOI
  149. Weng, 2019, Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation, Biomed. Pharmacother., 119, 109398, 10.1016/j.biopha.2019.109398 · DOI
  150. Banoglu, 2001, Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate, Eur. J. Drug Metab. Pharmacokinet., 26, 235, 10.1007/BF03226377 · DOI
  151. Kiernan, 2007, Indigogenic substrates for detection and localization of enzymes, Biotech. Histochem., 82, 73, 10.1080/10520290701375278 · DOI
  152. You, 2009, Effect of extracts from indigowood root (Isatis indigotica Fort.) on immune responses in radiation-induced mucositis, J. Altern. Complement. Med., 15, 771, 10.1089/acm.2008.0322 · doi:10.1089/acm.2008.0322
  153. Kunikata, 2000, Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity, Eur. J. Pharmacol., 410, 93, 10.1016/S0014-2999(00)00879-7 · DOI
  154. Uchiyama, K., Takami, S., Suzuki, H., Umeki, K., Mochizuki, S., Kakinoki, N., Iwamoto, J., Hoshino, Y., Omori, J., and Fujimori, S. (2020). Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial. PLoS ONE, 15. · doi:10.1371/journal.pone.0241337
  155. Naganuma, 2020, Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: A post hoc analysis from the INDIGO study, J. Gastroenterol., 55, 169, 10.1007/s00535-019-01625-2 · DOI
  156. Sugimoto, 2016, Clinical efficacy and safety of oral Qing-Dai in patients with ulcerative colitis: A single-center open-label prospective study, Digestion, 93, 193, 10.1159/000444217 · DOI
  157. Lin, 2007, The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis, Dermatology, 214, 155, 10.1159/000098576 · doi:10.1159/000098576
  158. Lin, 2008, Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis, Arch. Dermatol., 144, 1457, 10.1001/archderm.144.11.1457 · DOI
  159. Lin, 2020, Efficacy and safety of indigo naturalis ointment in treating atopic dermatitis: A randomized clinical trial: Indigo naturalis in treating atopic dermatitis, J. Ethnopharmacol., 250, 112477, 10.1016/j.jep.2019.112477 · DOI
  160. Lin, 2009, Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component, J. Dermatol. Sci., 54, 168, 10.1016/j.jdermsci.2009.02.007 · DOI
  161. Lin, 2013, Indigo naturalis upregulates claudin-1 expression in human keratinocytes and psoriatic lesions, J. Ethnopharmacol., 145, 614, 10.1016/j.jep.2012.11.044 · DOI
  162. Busbee, 2013, Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders, Nutr. Rev., 71, 353, 10.1111/nure.12024 · DOI · Paper page
  163. Zhang, 2003, Flavonoids as aryl hydrocarbon receptor agonists/antagonists: Effects of structure and cell context, Environ. Health Perspect., 111, 1877, 10.1289/ehp.6322 · DOI · Paper page
  164. Jin, 2018, Structure-dependent modulation of aryl hydrocarbon receptor-mediated activities by flavonoids, Toxicol. Sci., 164, 205, 10.1093/toxsci/kfy075 · DOI
  165. Bechoux, 2009, Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/synergic activities in human and rat reporter gene assays, Anal. Chim. Acta, 637, 337, 10.1016/j.aca.2008.09.054 · DOI
  166. Xue, 2017, Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor, Food Funct., 8, 1414, 10.1039/C6FO01810F · DOI
  167. Vezza, T., Rodríguez-Nogales, A., Algieri, F., Utrilla, M.P., Rodriguez-Cabezas, M.E., and Galvez, J. (2016). Flavonoids in inflammatory bowel disease: A review. Nutrients, 8. · DOI · Paper page
  168. Salaritabar, 2017, Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review, World J. Gastroenterol., 23, 5097, 10.3748/wjg.v23.i28.5097 · DOI · Paper page
  169. Coelho, 2001, Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat, Aliment. Pharmacol. Ther., 15, 2027, 10.1046/j.1365-2036.2001.01133.x · DOI
  170. Guazelli, 2013, Quercetin-loaded microcapsules ameliorate experimental colitis in mice by anti-inflammatory and antioxidant mechanisms, J. Nat. Prod., 76, 200, 10.1021/np300670w · DOI · Paper page
  171. Park, 2012, Dietary Kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice, Dig. Dis. Sci., 57, 355, 10.1007/s10620-011-1883-8 · DOI
  172. Wright, 2001, Predicting the activity of phenolic antioxidants: Theoretical method, analysis of substituent effects, and application to major families of antioxidants, J. Am. Chem. Soc., 123, 1173, 10.1021/ja002455u · DOI · Paper page
  173. Stivala, 2001, Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol, J. Biol. Chem., 276, 22586, 10.1074/jbc.M101846200 · DOI · Paper page
  174. Wang, 2012, Dietary flavonoid naringenin induces regulatory T cells via an aryl hydrocarbon receptor mediated pathway, J. Agric. Food Chem., 60, 2171, 10.1021/jf204625y · DOI · Paper page
  175. Michalski, 2020, Quercetin induces an immunoregulatory phenotype in maturing human dendritic cells, Immunobiology, 225, 151929, 10.1016/j.imbio.2020.151929 · DOI
  176. Schroeder, 2010, The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor, Biochemistry, 49, 393, 10.1021/bi901786x · DOI · Paper page
  177. Wikoff, 2009, Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites, Proc. Natl. Acad. Sci. USA, 106, 3698, 10.1073/pnas.0812874106 · DOI · Paper page
  178. Jin, 2014, Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities, Mol. Pharmacol., 85, 777, 10.1124/mol.113.091165 · DOI · Paper page
  179. Miller, 1997, Expression of the human Aryl hydrocarbon receptor complex in yeast, J. Biol. Chem., 272, 32824, 10.1074/jbc.272.52.32824 · DOI · Paper page
  180. Weems, 2010, 3-Methylindole metabolites induce lung CYP1A1 and CYP2F1 enzymes by AhR and non-AhR mechanisms, respectively, Chem. Res. Toxicol., 23, 696, 10.1021/tx9004506 · DOI
  181. Lamas, 2017, CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands, Nat. Med., 22, 598, 10.1038/nm.4102 · DOI · Paper page
  182. Takamura, 2011, Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis, Immunol. Cell Biol., 89, 817, 10.1038/icb.2010.165 · DOI · Paper page
  183. Chng, 2016, Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare, Nat. Microbiol., 1, 16106, 10.1038/nmicrobiol.2016.106 · DOI · Paper page
  184. Yu, 2019, A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor, J. Allergy Clin. Immunol., 143, 2108, 10.1016/j.jaci.2018.11.036 · DOI · Paper page
  185. Wille, 2001, Malassezin—A novel agonist of the Aryl hydrocarbon receptor from the yeast Malassezia furfur, Bioorganic Med. Chem., 9, 955, 10.1016/S0968-0896(00)00319-9 · DOI
  186. Gaitanis, 2008, AhR ligands, malassezin, and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis, J. Invest. Dermatol., 128, 1620, 10.1038/sj.jid.5701252 · DOI
  187. Magiatis, 2014, Malassezia yeasts produce a collection of exceptionally potent activators of the Ah (dioxin) receptor detected in diseased human skin, J. Invest. Dermatol., 133, 2023, 10.1038/jid.2013.92 · DOI · Paper page
  188. Mexia, 2015, Pityriazepin and other potent AhR ligands isolated from Malassezia furfur yeast, Arch. Biochem. Biophys., 571, 16, 10.1016/j.abb.2015.02.023 · DOI
  189. Buommino, 2018, Malassezia pachydermatis up-regulates AhR related CYP1A1 gene and epidermal barrier markers in human keratinocytes, Med. Mycol., 56, 987
  190. Buommino, 2013, Innate immune response in human keratinocytes infected by a feline isolate of Malassezia pachydermatis, Vet. Microbiol., 163, 90, 10.1016/j.vetmic.2012.12.001 · doi:10.1016/j.vetmic.2012.12.001
  191. Buommino, 2016, Correlation between genetic variability and virulence factors in clinical strains of Malassezia pachydermatis of animal origin, New Microbiol., 39, 216
  192. Furue, M., and Tsuji, G. (2019). Chloracne and hyperpigmentation caused by exposure to hazardous aryl hydrocarbon receptor ligands. Int. J. Environ. Res. Public Health, 16. · DOI · Paper page
  193. Baron, 2001, Expression of multiple cytochrome P450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes, J. Invest. Dermatol., 116, 541, 10.1046/j.1523-1747.2001.01298.x · DOI · Paper page
  194. Tanaka, 2018, Tryptophan photoproduct FICZ upregulates IL1A, IL1B, and IL6 Expression via oxidative stress in keratinocytes, Oxid. Med. Cell. Longev., 2018, 9298052, 10.1155/2018/9298052 · DOI · Paper page
  195. Smith, 2017, Editor’s highlight: Ah receptor activation potentiates neutrophil chemoattractant (C-X-C Motif) ligand 5 expression in keratinocytes and skin, Toxicol. Sci., 160, 83, 10.1093/toxsci/kfx160 · DOI
  196. Ray, 2003, Alteration of keratinocyte differentiation and senescence by the tumor promoter dioxin, Toxicol. Appl. Pharmacol., 192, 131, 10.1016/S0041-008X(03)00277-1 · DOI
  197. Greenlee, 1985, Actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human epidermal keratinocytes in culture, Vitr. Cell. Dev. Biol., 21, 509, 10.1007/BF02620843 · DOI
  198. Um, 2020, 2,3,7,8-Tetrachlorodibenzo-p-dioxin regulates the expression of aryl hydrocarbon receptor-related factors and cytokines in peripheral blood mononuclear cells and CD4+ T cells from patients with atopic dermatitis and psoriasis, Ann. Dermatol., 32, 360, 10.5021/ad.2020.32.5.360 · DOI
  199. Richardson, 1988, Identification of an anthraquinone pigment and a hydroxystilbene antibiotic from Xenorhabdus luminescens, Appl. Environ. Microbiol., 54, 1602, 10.1128/aem.54.6.1602-1605.1988 · DOI · Paper page
  200. Li, 1995, Identification of two pigments and a hydroxystilbene antibiotic from Photorhabdus luminescens, Appl. Environ. Microbiol., 61, 4329, 10.1128/aem.61.12.4329-4333.1995 · DOI · Paper page

200 of 206 shown

Cited by

See all 133

Metadata

Authors
Fernández-Gallego, N., Sánchez-Madrid, F., & Cibrian, D.
Venue
Cells
Publisher
MDPI AG
Published
2021-11-15
Volume
10
Issue
11
Pages
3176
ISSN
2073-4409 (ISSN-L)
OpenAlex
W3211489143
Cited by
133
References
43
FWCI
12.23
Type
journal article
Language
en
Open access
gold
Funders
Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2017-82886-R and PDI-2020-120412RB-I00)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.